Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17].

Gil-Jimenez, Alberto; van Dorp, Jeroen; Contreras-Sanz, Alberto; van der Vos, Kristan; Vis, Daniel J; Braaf, Linde; Broeks, Annegien; Kerkhoven, Ron; van Kessel, Kim E M; Ribal, María José; Alcaraz, Antonio; Wessels, Lodewyk F A; Seiler, Roland; Wright, Jonathan L; Mengual, Lourdes; Boormans, Joost; van Rhijn, Bas W G; Black, Peter C; van der Heijden, Michiel S (2023). Corrigendum to "Assessment of Predictive Genomic Biomarkers for Response to Cisplatin-based Neoadjuvant Chemotherapy in Bladder Cancer" [Eur Urol 2023;83:313-17]. European urology, 83(6), e165. Elsevier 10.1016/j.eururo.2023.03.002

[img] Text
1-s2.0-S0302283823026416-main.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (226kB)

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie
04 Faculty of Medicine > Pre-clinic Human Medicine > BioMedical Research (DBMR) > DBMR Forschung Mu35 > Forschungsgruppe Urologie

UniBE Contributor:

Seiler-Blarer, Roland

Subjects:

600 Technology > 610 Medicine & health

ISSN:

1873-7560

Publisher:

Elsevier

Language:

English

Submitter:

Pubmed Import

Date Deposited:

13 Mar 2023 12:33

Last Modified:

15 May 2023 00:14

Publisher DOI:

10.1016/j.eururo.2023.03.002

Related URLs:

PubMed ID:

36907692

BORIS DOI:

10.48350/179930

URI:

https://boris.unibe.ch/id/eprint/179930

Actions (login required)

Edit item Edit item
Provide Feedback